1232061-78-7

Basic information

• Product Name: N-(4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl)-1-piperazin-1-yl-2,3-dihydro-1H-indene-5-carboxamide
• Synonyms: N-(4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl)-1-piperazin-1-yl-2,3-dihydro-1H-indene-5-carboxamide
• CAS NO: 1232061-78-7
• Molecular Weight: 505.622
• Mol File: 1232061-78-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl)-1-piperazin-1-yl-2,3-dihydro-1H-indene-5-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl)-1-piperazin-1-yl-2,3-dihydro-1H-indene-5-carboxamide(1232061-78-7)
• EPA Substance Registry System: N-(4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl)-1-piperazin-1-yl-2,3-dihydro-1H-indene-5-carboxamide(1232061-78-7)

Safety Data

• Hazardous Substances Data: 1232061-78-7(Hazardous Substances Data)

Upstream product

• 1232061-74-3 tert-Butyl 4-{5-[({4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}amino) carbonyl]-2,3-dihydro-1H-inden-1-yl}piperazin-1-carboxylate 
• 1232062-60-0 1-[4-(BOC) piperazin-1-yl]-2,3-dihydro-1H-indene-5-carboxylic acid 
• 1232062-56-4 tert-Butyl 4-[5-(Ethoxycarbonyl)-2,3-dihydro-1H-inden-1-yl) piperazin-1-carboxylate 
• 1232062-52-0 tert-Butyl-4-(5-Bromo-2,3-dihydro-1H-inden-1-yl) piperazin-1-carboxylate 
• 34598-49-7 5-Bromo-1-indanone 
• 158330-91-7 5-bromo-1-chloro-indane 
• 34598-50-0 5-bromo-1-indanol 

Relevant articles and documents

PREPARATION METHOD OF DIHYDROINDENE AMIDE COMPOUNDS THEIR PHARMACEUTICAL COMPOSITIONS CONTAING COMPOUNDS THEREOF AND USE AS PROTEIN KINASES INHIBITOR

The invention provides a new kind of dihydroindene amide compounds of general formula I or their pharmaceutically acceptable salts or prodrug thereof which can be used as protein kinase inhibitor. The invention provides a preparation method of the kind of compounds, the pharmaceutical compositions containing the compounds, the method for preventing or curing the diseases related to the abnormity of activities of protein kinases, especially Abl, Bcr-Abl, c-Kit and PDGFR, using them as protein kinase inhibitor, and their preparation use of drug used for preventing or curing the diseases related to the abnormity of activities of protein kinases, especially Abl, Bcr-Abl, c-Kit and PDGFR,